SURVEILLANCE HEARTCARE® OUTCOMES REGISTRY (SHORE) Save

Date Added
June 19th, 2019
PRO Number
Pro00086580
Researcher
Adrian Van Bakel

List of Studies

Silhouette
Keywords
Cardiovascular
Summary

The purpose of this registry is to observe outcomes of heart transplant recipients who are managed with HeartCare. This is done by collecting information about the participant's heart transplant such as test results, biopsy results, and outcomes, storing that information in a database, and using that information for research. HeartCare is a combination of two tests from one blood draw. One test, AlloMap®, is a well-established test for heart transplant recipients. The other test, AlloSure-Heart, is a new test that directly measures injury of the transplanted heart. HeartCare provides the results of both tests for a noninvasive assessment at time of testing. The registry will be active for up to 5 years after enrollment.

Institution
MUSC
Recruitment Contact
Anthony Awkar
8438765009
awkar@musc.edu

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients with Heart Failure and Impaired Systolic Function Save

Date Added
March 28th, 2017
PRO Number
Pro00063152
Researcher
Adrian Van Bakel

List of Studies

Silhouette
Keywords
Cardiovascular, Heart
Summary

The purpose of this study is to evaluate the safety, and effectiveness of BMS-986231 (HNO DONOR) in patients with acute heart failure when added to the standard treatment. Reduced strength of contraction can mean that your heart is not pumping most of the blood out of your heart with each beat. The study drug will be given as a continuous 48-hour infusion (through an IV) during the hospital stay. There will be a follow up visit at 30 days. All adults who meet inclusion criteria will be approached for this study.

Institution
MUSC
Recruitment Contact
Anna Tecklenburg
8437925863
tecklenb@musc.edu

Barostim neo- Baroreflex Activation Therapy for Heart Failure Save

Date Added
May 26th, 2015
PRO Number
Pro00044328
Researcher
Adrian Van Bakel

List of Studies

Silhouette
Keywords
Cardiovascular, Heart
Summary

The purpose of this study is to show whether the Barostim Neo system is safe and works in people with heart failure. The device is designed to stimulate the body's natural cardiovascular regulators in your neck to potentially improve your heart failure condition.

Institution
MUSC
Recruitment Contact
Mariann Schulz
843-876-5009
schulzmt@musc.edu

Change_preferences

-- OR --

Create_login